Table 6.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 2000 to 2009

Recipients with Pancreas Transplant Alone (PTA) Transplants

	Transplant Year
	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008
Functioning Graft at Discharge	113	151	168	141	170	181	153	188	202	164
With Immunosuppression Info	113	150	168	139	169	181	152	186	201	161
Tac	16.8%	19.3%	22.6%	17.3%	13.0%	17.7%	10.5%	6.5%	6.5%	7.5%
--- + MMF/MPA	0.0%	0.0%	0.6%	11.5%	19.5%	2.8%	0.0%	0.0%	0.0%	0.0%
CyA + MMF/MPA	0.0%	0.7%	1.2%	0.7%	0.6%	0.0%	0.7%	1.1%	0.0%	0.0%
Tac + MMF/MPA	0.9%	0.0%	1.2%	5.0%	8.3%	17.1%	18.4%	20.4%	29.4%	36.6%
Tac + OtherAntimet	0.0%	0.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
--- + Siro/Evero	0.0%	0.0%	0.6%	0.7%	0.6%	0.0%	0.0%	0.0%	0.0%	0.0%
CyA + Siro/Evero	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.7%	0.0%	0.0%	1.2%
Tac + Siro/Evero	1.8%	1.3%	1.8%	10.8%	7.1%	6.6%	3.9%	1.6%	1.0%	0.6%
--- + MMF/MPA + Siro/Evero	0.0%	0.0%	0.0%	0.7%	0.0%	0.6%	0.0%	0.0%	0.0%	0.6%
CyA + MMF/MPA + Siro/Evero	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.5%	0.0%	0.0%
Tac + MMF/MPA + Siro/Evero	0.0%	0.7%	3.0%	0.0%	1.2%	3.3%	12.5%	11.8%	6.5%	8.7%
--- + Steroids	0.9%	0.0%	0.6%	0.7%	1.8%	3.3%	1.3%	1.1%	1.0%	0.0%
CyA + Steroids	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.5%	0.0%
Tac + Steroids	4.4%	12.0%	7.1%	7.9%	15.4%	11.0%	21.1%	28.5%	25.4%	21.7%
--- + MMF/MPA + Steroids	0.0%	0.0%	0.0%	0.7%	0.6%	0.0%	0.0%	1.1%	1.0%	0.0%
CyA + MMF/MPA + Steroids	3.5%	3.3%	1.2%	0.7%	0.0%	0.0%	0.7%	0.5%	0.0%	0.0%
Tac + MMF/MPA + Steroids	61.9%	54.0%	48.8%	38.1%	28.4%	33.1%	20.4%	22.0%	23.9%	19.3%
Tac + OtherAntimet + Steroids	1.8%	0.7%	0.6%	0.0%	1.2%	0.0%	0.0%	1.1%	0.0%	0.0%
--- + Siro/Evero + Steroids	0.0%	0.7%	0.0%	0.7%	0.6%	0.6%	0.7%	0.0%	0.0%	0.0%
CyA + Siro/Evero + Steroids	0.9%	0.0%	0.6%	0.7%	0.6%	0.0%	0.0%	0.0%	0.0%	0.0%
Tac + Siro/Evero + Steroids	4.4%	4.7%	7.1%	1.4%	0.6%	3.3%	6.6%	3.2%	2.5%	3.1%
Other Regimen	2.7%	2.0%	3.0%	2.2%	0.6%	0.6%	2.6%	0.5%	2.5%	0.6%

Source: OPTN/SRTR Data as of October 1, 2010.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.